Wall Street analysts are maintaining Buy rating on Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) company shares. The one year target on the name currently stands at $120.00. The stock recently touched $69.75 and has moved in the range of $68.05 - 70.31 during the current session. Based on a recent bid this places the stock +35.41% away from the 52-week floor of $51.51 and -50.18% away from the 52-week ceiling of $140.00.
When stocks are given “Buy” ratings by analysts, the reasons or criteria for that recommendation can greatly vary. Typically when a stock is given this label, analysts are expecting that the stock will outperform their peers, their sector or the market over a 6 to 12 month time frame. Several factors might include near-term catalysts, future earnings growth. Many analysts only give a Buy recommendation when they expect that the stock will yield a return of at least 5-10% over the course of a year. Since analyst criteria and recommendation terminology can differ, we can look at consensus numbers to get a feel of overall analyst sentiment.
CaesarStone Sdot-Yam Ltd. (NASDAQ:CSTE) has been given a consensus Buy rating by analysts on Wall Street. According to Thomson Reuters' First Call, research brokers have a one year price target of $43.8300 on the stock. The stock is currently trading -7.8847% away from its 200-day moving average of $36.8016. Based on a recent trade, shares of CaesarStone Sdot-Yam Ltd. are -52.9233% away from the 52-week high of $72.0100 and +24.1300% away from the 52-week low of $27.3100.
Analysts are estimating that the company will report earnings of $2.5900 for the current year and $0.7100 for next quarter. The stock closed the most recent trading session at $33.0200.
Shares of Lattice Semiconductor Corporation (NASDAQ:LSCC) continue to be viewed favorably by equities brokerage firms on Wall Street. The First Call consensus which is calculated by Thomson Reuters has a $7.65 price target and Buy rating according to the covering analysts. During today’s session the stock hit $5.26 or -2.95% from the previous close, while moving in the range of $5.17 - 5.43.
Shares of Xencor, Inc. (NASDAQ:XNCR) continue to be viewed favorably by equities brokerage firms on Wall Street. The First Call consensus which is calculated by Thomson Reuters has a $23.25 price target according to the covering analysts. During today’s session the stock hit $13.83 or +4.77% from the previous close, while moving in the range of $13.87 - 14.49. This puts the stock -41.62% away from the 52-week high of $24.82 and +46.51% away from the 52-week low of $9.89.
Exact definitions of a “Buy” rating can greatly vary depending on the equity research firm. The consensus rating simply provides an average of those recommendations. It's important to note that a “Buy” rating does not mean that every investor should acquire the stock. It is just a single factor among many that should be considered before making an investment decision.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with MarketBeat.com’s FREE daily email newsletter.
